If you’ve seen recent headlines about new breast cancer screening recommendations, you’re not alone.
The American College of Physicians (ACP) recently released updated guidelines in April 2026 recommending that routine mammograms begin at age 50 for women at average risk, with screening every other year until age 74. The recommendations have sparked widespread discussion—and concern—across the breast cancer community.
The ACP’s reasoning centers on the potential harms of earlier screening: false positives, unnecessary biopsies, and the anxiety that can come with additional testing. These are real considerations. But many experts believe they are outweighed by what earlier screening makes possible.
Notably, the U.S. Preventive Services Task Force—whose recommendations influence insurance coverage nationwide—moved in the opposite direction in 2024, lowering its recommended starting age from 50 to 40, citing rising breast cancer rates among women in their 40s.
And many of the nation’s leading organizations dedicated to breast cancer detection, diagnosis, and treatment — including the American College of Radiology, the Society of Breast Imaging, the National Comprehensive Cancer Network, and the American Society of Breast Surgeons— go further still. They continue to recommend annual mammograms beginning at age 40 for women at average risk, with earlier screening and additional imaging for women at higher risk based on their family history, genetics, race, breast density, or other factors.
So why does this matter?
Early Detection Changes Everything
Breast cancer is most treatable when it is found early. An annual mammogram can detect cancers before they can be felt—often when they are smaller, easier to treat, and less likely to have spread beyond the breast.
Early detection doesn’t simply improve survival; it can also mean less aggressive treatment. Women whose cancers are detected early are more likely to avoid extensive surgery, intensive chemotherapy, and advanced disease. For many patients, finding breast cancer months—or even years—earlier can make a profound difference in both treatment options and quality of life.
Decades of research, including Lynn Sage funded work by Principal Investigator (PI) Dr. Lisa Stempel to support optimized and personalized screening guidelines at RUSH MD Anderson Cancer Center, have demonstrated the impact of routine screening based on a women’s risk. Indeed, data suggests that for every 1,000 women screened annually versus biannually over a 10-year period, 19 lives can potentially be saved, thanks to the benefits of earlier detection.
One Woman’s Risk Is Not Another’s
Perhaps the most important takeaway from the recent discussions about screening guidelines is that there is no single recommendation that’s right for every woman. Age is only one piece of the picture. Family history, inherited genetic mutations, breast density, personal medical history, and ancestry all influence an individual’s risk of developing breast cancer.
For example, Black women are more likely to be diagnosed with breast cancer at younger ages, are disproportionately affected by aggressive subtypes such as triple-negative breast cancer, and are more likely to die from the disease than women of other racial and ethnic groups. Therefore, some guidelines suggest starting risk-assessment discussions with their doctors at age 25. Women with BRCA1 or BRCA2 mutations or a strong family history may benefit from screening years before age 40. Other women may need supplemental imaging in addition to mammography.
The Future of Screening Is Personal
As our understanding of breast cancer continues to evolve, so does the science behind screening. Researchers are increasingly moving beyond age-based recommendations toward more personalized approaches that consider each woman’s unique individual risk.
This is one reason Lynn Sage is proud to support innovative research like that of Lynn Sage Scholar Dr. Dezheng Huo, whose work is exploring how artificial intelligence can combine imaging and genetic information to better predict an individual’s breast cancer risk. His research could one day help physicians identify who may benefit from earlier screening, more frequent imaging, or additional preventive strategies long before cancer develops.
Lynn Sage is also proud to partner with Northwestern Medicine, whose Breast Imaging program is led by Lynn Sage Medical Advisory Board member Dr. Georgia Spear. Dr. Spear is leading the charge by leveraging the latest technology—including new imaging methods and AI—to support a variety of patient experience and quality improvement initiatives, including a Breast Density Assessment tool to help identify patients who may benefit from supplemental screening.
Lynn Sage is proud to be supporting a future where screening isn’t based solely on age, but on a more complete understanding of each woman’s individual risk.
What Women Should Know
While professional organizations may differ on specific recommendations, one message remains remarkably consistent: Early detection saves lives.
No matter your age, ask your healthcare provider about a formal breast cancer risk assessment. The American College of Radiology recommends having one by age 25, so you can understand your personal risk and create an individualized screening plan early.
If you’re 40 or older, talk with your healthcare provider about annual mammograms.
If you have a family history of breast cancer, dense breasts, a known genetic mutation, or other risk factors, ask whether you should begin screening earlier or consider additional imaging.
As research continues to advance, we’re moving closer to a future where every woman receives screening that’s personalized to her individual risk, not just her age. Because the most important screening recommendation is the one that’s right for you.